Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas

Human Pathology

Volumn 29, Issue 9, 1998, Pages 961-964

  Fogt, Franz ^a   Vortmeyer, Alexander O ^b   Stolte, Manfred ^b   Mueller, Elke ^b   Mueller, James ^b   Noffsinger, Amy ^b   Poremba, Christopher ^b   Zhuang, Zhengping ^b  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Chromosome 3; Loss of heterozygosity; Ulcerative colitis; Von Hippel Lindau gene

Indexed keywords

ADENOMA; ADENOMATOUS POLYP; ADULT; ARTICLE; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3; CLINICAL ARTICLE; COLON RESECTION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; MALE; STEM CELL; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; VON HIPPEL LINDAU DISEASE;

EID: 0031682605     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90201-5     Document Type: Article

References (26)

1. Shelton AA, Lehman RE, Schrock TR, et al: Retrospective review of colorectal cancer in ulcerative colitis at a tertiary center. Arch Surg 131:806-810, 1996
2. Blackstone MO, Riddell RH, Rogers BH, et al: Dysplasia associated lesion or mass (DALM) detected by colonoscopy in long standing ulcerative colitis: an indication for colectomy. Gastroenterology 80:366-374, 1981
3. Schneider A, Stolte M: Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol 31:653-656, 1993
4. Rubio CA, Rodensjoe MJ: p53 overexpression in flat serrated adenomas and flat tubular adenomas of the colorectal mucosa. Cancer Res Oncol 121:571-576, 1995
5. Nishisho I, Nakamura Y, Miyoshi Y, et al: Mutations of chromosome 5q21 genes in FAP and colorectal cancer. Science 253:665-669, 1991
6. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal tumor development. N Engl J Med 319:525-532, 1988
7. Zhuang Z, Emmert-Buck MR, Roth MJ, et al: Von Hippel Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. HUM PATHOL 27:152-156, 1996
8. Zhuang Z, Bertheau P, Emmert-Buck M, et al: A new microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter in size. Am J Pathol 146:620-625, 1995
9. Greenwald BD, Harpaz N, Yin J, et al: Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52:741-745, 1992
10. Tarmin L, Yin J, Harpaz N, et al: Adenomatous polyposis coli gene mutations in ulcerative colitis associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55:2035-2038, 1995
11. Fogt F, Vortmeyer AO, Goldman H, et al: Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma. HUM PATHOL 29:131-136, 1998
12. Benhattar J, Saraga E: Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer 31A:1171-1173, 1995
13. Vogelstein B, Fearon ER, Kern SE, et al: Allelotype of colorectal carcinomas. Science 244:207-211, 1989
14. Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-439, 1994
15. Lennard-Jones JE, Melville DM, Morson BC, et al: Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years. Gut 31:800-806, 1990
16. Cho KR, Vogelstein B: Suppressor gene alteration in the colorectal adenoma-carcinoma sequence. J Cell Biochem 16G:137-141, 1992 (suppl)
17. De Benedetti L, Sciallero S, Gismondi V, et al: Association of APC gene mutations and histological characteristics of colorectal adenomas. Cancer Res 54:3553-3556, 1994
18. Fearon ER: Molecular abnormalities in colon and rectal cancer, in Mendelsohn J, Howley PM, Israel MA, et al (eds): The Molecular Basis of Cancer. Philadelphia, PA, Saunders, 1995, pp 340-357
19. Chaubert P, Benhattar J, Saraga E, et al: K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 144:767-775, 1994
20. Benhattar J, Saraga E: Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer 31A:1171-1173, 1995
21. Burmer GC, Rabinovitch RS, Haggitt RC, et al: Neoplastic progression in ulcerative colitis: Histology, DNA content and loss of a p53 allele. Gastroenterology 103:1602-1610, 1992
22. Krishna M, Woda B, Savas L, et al: Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod Pathol 8:654-657, 1995
23. Ilyas M, Talbot IC: p53 expression in ulcerative colitis: A longitudinal study. Gut 37:802-804, 1992
24. Bernstein CN, Shanahan F, Weinstein WM: Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 343:71-74, 1994
25. Odze R, Kraus M, Antonioli D: Clinicapathologic evaluation of adenomas and polypoid dysplastic lesions in chronic ulcerative colitis (CUC). Mod Pathol 9:63A, 1996
26. Brentnall TA, Crispin DA, Rabinovitch PS, et al: Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369-378, 1994